About
Cellemedy is a biotechnology company developing next-generation therapeutic proteins aimed at replacing conventional antibody treatments, with a focus on immunotherapy and oncology drug conjugates.
Explore Cellemedy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.